Cellyan Biotechnology Co Ltd (HKPD)
Cellyan Biotechnology Co., Ltd. is a Hong Kong-based company incorporated in 2023 and listed on NASDAQ as common stock under the ticker HKPD. The company operates as an investment holding company with activities centered on the over-the-counter pharmaceutical sector in Hong Kong and Mainland China. Its business includes cross-border procurement and distribution of OTC pharmaceuticals, along with e-commerce supply chain services. The company also provides related logistics support such as customs clearance, drug registration services, warehousing, and other supply chain functions. Cellyan Biotechnology serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was previously known as Hong Kong Pharma Digital Technology Holdings Limited and adopted its current name in December 2025. It is based in Yau Tong, Hong Kong.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-HKPD
|
$2.54
|
86.8% Upside
|
Bargain
|
Not available
|
Not available
|
Weak
|
0.0%
|
0.2x
|
0.1x
|
1.598 M
|
2.634 M
|
39.8%
|
10.6
|
69.3%
|
